ReNerve Secures Marketing Approval in Thailand for Nerve Repair Product; Shares Hit All-Time Low

MT Newswires Live

2025/03/12

ReNerve (ASX:RNV) received marketing approval for its NervAlign Nerve Cuff product in Thailand, according to a Tuesday filing with the Australian bourse.

The NervAlign Nerve Cuff product is designed to safeguard repaired nerves and promote regeneration during the healing process following peripheral nerve injuries, the filing said.

The company also received an initial stocking order for NervAlign Nerve Cuff from its first hospital customer in Hong Kong, per the filing.

Shares fell 4% in midday trade Wednesday, and earlier hit an all-time low.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2518943081"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2518943081\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2518943081?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-12 10:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2518943081","market":"us","top_or_hot":-1,"title":"ReNerve Secures Marketing Approval in Thailand for Nerve Repair Product; Shares Hit All-Time Low","media":"MT Newswires Live","content":"<html><body><p> ReNerve (ASX:RNV) received marketing approval for its NervAlign Nerve Cuff product in Thailand, according to a Tuesday filing with the Australian bourse.</p><p>The NervAlign Nerve Cuff product is designed to safeguard repaired nerves and promote regeneration during the healing process following peripheral nerve injuries, the filing said.</p><p>The company also received an initial stocking order for NervAlign Nerve Cuff from its first hospital customer in Hong Kong, per the filing.</p><p>Shares fell 4% in midday trade Wednesday, and earlier hit an all-time low.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ReNerve Secures Marketing Approval in Thailand for Nerve Repair Product; Shares Hit All-Time Low</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReNerve Secures Marketing Approval in Thailand for Nerve Repair Product; Shares Hit All-Time Low\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-12 10:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> ReNerve (ASX:RNV) received marketing approval for its NervAlign Nerve Cuff product in Thailand, according to a Tuesday filing with the Australian bourse.</p><p>The NervAlign Nerve Cuff product is designed to safeguard repaired nerves and promote regeneration during the healing process following peripheral nerve injuries, the filing said.</p><p>The company also received an initial stocking order for NervAlign Nerve Cuff from its first hospital customer in Hong Kong, per the filing.</p><p>Shares fell 4% in midday trade Wednesday, and earlier hit an all-time low.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RNV.AU","symbol_name":"Renerve Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2518943081","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2518943081","pubTimestamp":1741746333,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"ReNerve  received marketing approval for its NervAlign Nerve Cuff product in Thailand, according to a Tuesday filing with the Australian bourse.The NervAlign Nerve Cuff product is designed to safeguard repaired nerves and promote regeneration during the healing process following peripheral nerve injuries, the filing said.The company also received an initial stocking order for NervAlign Nerve Cuff from its first hospital customer in Hong Kong, per the filing.Shares fell 4% in midday trade Wednesday, and earlier hit an all-time low.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RNV.AU":"Renerve Ltd","BK7126":"医疗保健用品"},"translate_title":"ReNerve神经修复产品在泰国获得上市批准；股价创历史新低","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RNV.AU":0.9},"content_text":"ReNerve (ASX:RNV) received marketing approval for its NervAlign Nerve Cuff product in Thailand, according to a Tuesday filing with the Australian bourse.The NervAlign Nerve Cuff product is designed to safeguard repaired nerves and promote regeneration during the healing process following peripheral nerve injuries, the filing said.The company also received an initial stocking order for NervAlign Nerve Cuff from its first hospital customer in Hong Kong, per the filing.Shares fell 4% in midday trade Wednesday, and earlier hit an all-time low.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}